New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color
Oncology January 30,2024
Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color
Oncology January 30,2024
Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

by Sabine Waasdorp,Leiden UniversityCredit: Unsplash/CC0 Public DomainMany people think heavy metals are poisonous and always harm people and the environment. The reality is more nuanced, says P
Oncology January 30,2024
Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

Heavy metals have a bad reputation but they can also help cure cancer, claims researcher

by Sabine Waasdorp,Leiden UniversityCredit: Unsplash/CC0 Public DomainMany people think heavy metals are poisonous and always harm people and the environment. The reality is more nuanced, says P
Oncology January 30,2024
Vaccine boosts response of engineered T cells, may help eradicate solid tumors

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How
Oncology January 30,2024
Vaccine boosts response of engineered T cells, may help eradicate solid tumors

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How
Oncology January 30,2024
Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti
Oncology January 30,2024
Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti
Oncology January 30,2024
Study brings insight to kidney cancer with gene mutation

Study brings insight to kidney cancer with gene mutation

by Anna Megdell,University of MichiganCredit: Pixabay/CC0 Public DomainA new study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology
Oncology January 30,2024
Study brings insight to kidney cancer with gene mutation

Study brings insight to kidney cancer with gene mutation

by Anna Megdell,University of MichiganCredit: Pixabay/CC0 Public DomainA new study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology
Oncology January 30,2024
Possible therapeutic approach to fight incurable blood cancer

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It
Oncology January 30,2024
Possible therapeutic approach to fight incurable blood cancer

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It
Oncology January 30,2024
A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in
Oncology January 30,2024
A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in
Oncology January 30,2024
Researchers show how a tumor cell's location and environment affect its identity

Researchers show how a tumor cell's location and environment affect its identity

by National Institutes of HealthDifferences in cell layers' fluorescent-dye uptake in a model of high-grade serous ovarian cancer. Credit: David B. Morse.Using 3D models of ovarian cancer tum
Oncology January 30,2024
Researchers show how a tumor cell's location and environment affect its identity

Researchers show how a tumor cell's location and environment affect its identity

by National Institutes of HealthDifferences in cell layers' fluorescent-dye uptake in a model of high-grade serous ovarian cancer. Credit: David B. Morse.Using 3D models of ovarian cancer tum
Oncology January 30,2024
Researchers analyze cancer discrepancies among young Black men in the South

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent
Oncology January 30,2024
Researchers analyze cancer discrepancies among young Black men in the South

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent
Oncology January 30,2024
Support for home cancer testing

Support for home cancer testing

by Flinders UniversityCredit: Pixabay/CC0 Public DomainScreening for bowel cancer using at-home fecal immunochemical tests could help to reduce the frequency of colonoscopies for some at above-av
Oncology January 30,2024
Support for home cancer testing

Support for home cancer testing

by Flinders UniversityCredit: Pixabay/CC0 Public DomainScreening for bowel cancer using at-home fecal immunochemical tests could help to reduce the frequency of colonoscopies for some at above-av
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com